People | December 04, 2025
Jubilant Pharmova appoints Daniel J. O Connor as CEO of Jubilant Therapeutics
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
Future of manufacturing lies in mobility based manufacturing
Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Sapala Organics
Sales from Novo’s GLP-1 portfolio—including Wegovy for obesity and Ozempic for type 2 diabetes reached $5.6 billion
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
Miels will formally assume the role on January 1, 2026
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
Subscribe To Our Newsletter & Stay Updated
